NASDAQ:NEPH Nephros Q1 2025 Earnings Results & Report $3.53 +0.24 (+7.29%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$3.53 0.00 (0.00%) As of 10/9/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Nephros beat analyst expectations on both earnings and revenue in its Q1 2025 results, released May 15, 2025. The company reported EPS of $0.0526 versus the -$0.0050 consensus estimate, while revenue of $4.88 million topped the $3.67 million estimate by $1.21 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2025Report DateMay 15, 2025TimeAfter Market ClosesConference Call DateMay 8, 2025Conference Call4:00 PM ET Nephros EPS ResultsActual EPS$0.0526Consensus EPS -$0.0050Beat/MissBeat by +$0.0576One Year Ago EPSN/AEPS Beat Rate5 of last 8 quartersNephros Revenue ResultsActual Revenue$4.88 millionExpected Revenue$3.67 millionBeat/MissBeat by +$1.21 millionYoY Revenue GrowthN/AUpcoming EarningsNephros' Q3 2026 earnings is estimated for Thursday, November 5, 2026, based on past reporting schedules, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q3 2026 Earnings ReportConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Nephros Q1 2025 Earnings FAQ Did Nephros beat earnings estimates for Q1 2025? Nephros (NASDAQ:NEPH) reported earnings of $0.0526 per share for Q1 2025, beating the consensus estimate of -$0.0050. The report was announced on Thursday, May 15, 2025. What was Nephros' revenue for Q1 2025? Nephros reported revenue of $4.88 million for Q1 2025, against a consensus estimate of $3.67 million. When is Nephros' next earnings date? Nephros' next earnings date is estimated for Thursday, November 5, 2026. MarketBeat tracks confirmed and estimated earnings dates for Nephros on the company's earnings history page. Nephros Earnings HeadlinesNephros (NASDAQ:NEPH) and TransMedics Group (NASDAQ:TMDX) Critical AnalysisOctober 1, 2026 | americanbankingnews.comNephros (NEPH) Q2 2026 Earnings Call TranscriptAugust 13, 2026 | finance.yahoo.comFirst Look: Elon’s “Starphone”Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.October 10 at 1:00 AM | Stansberry Research (Ad)Nephros details integrated water safety platform while expanding in Greater New York and Puerto RicoAugust 6, 2026 | seekingalpha.comNephros, Inc. (NEPH) Q2 2026 Earnings Call TranscriptAugust 6, 2026 | seekingalpha.comNephros Schedules Second Quarter 2026 Financial Results Conference CallAugust 5, 2026 | globenewswire.comSee More Nephros Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Nephros? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nephros and other key companies, straight to your email. Email Address About NephrosNephros (NASDAQ:NEPH), Inc. is a medical device company that develops and sells filtration products for healthcare and commercial applications. Its primary focus is point-of-use water filtration systems designed to help reduce bacteria, including waterborne pathogens such as Legionella, in hospitals, long-term care facilities, and other healthcare settings. The company’s product portfolio includes disposable and durable water filtration systems intended for use at sinks, showers, and other water outlets. Nephros also has a history of developing ultrafiltration products for blood purification and hemodialysis applications, although its business has increasingly emphasized water filtration solutions. Nephros serves customers primarily in the United States through healthcare providers, distributors, and commercial partners. Its products are used in settings where water quality and infection-control practices are important, including hospitals, nursing facilities, and other institutional environments.View Nephros ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Delta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
